Research Summary
Research Summary
11/13/2026
Brian McCurdy
A retrospective cohort study of 587 patients with metastatic cancer linked influenza vaccination during checkpoint inhibitor therapy to longer progression-free survival, without significantly higher IRAE...
11/13/2026
Research Summary
Research Summary
11/13/2026
Brian McCurdy
A cohort study found COVID-19 vaccination was associated with approximately 7 additional SIRVA cases per 100,000 vaccinations compared with influenza
11/13/2026
Research Summary
Research Summary
11/13/2026
Brian McCurdy
An English cohort emulating a randomized trial linked influenza vaccination to lower influenza hospitalization risk in adults ≥40 with COPD, although residual confounding remained.
11/13/2026
Video
Video
10/13/2026
William Schaffner, MD
Dr. William Schaffner, MD, reviews evolving adult vaccination guidance and key opportunities to prevent severe disease in clinical practice.
10/13/2026
Research Summary
Research Summary
09/24/2026
Kate Young
A multisite surveillance study published in Pediatrics assessed trends and determinants of influenza antiviral use in hospitalized children across the United States before and during the late COVID-19...
09/24/2026
Vaccine Guideline
Vaccine Guideline
09/21/2026
Anthony Calabro, MA
CDC retained prior influenza vaccine recommendations for 2026–2027 and detailed vaccine selection, timing, dosing, and precautions.
09/21/2026
Research Summary
Research Summary
09/21/2026
Anthony Calabro, MA
In an emulated trial of 56,652 matched pairs with COPD, vaccination was associated with a 39% lower hazard of hospitalized influenza.
09/21/2026
FDA Approval Timeline
Notable FDA Approvals
FDA Approval Timeline
09/01/2026
August 2026 included several FDA drug and biologic approvals across a range of therapeutic areas. This timeline highlights the key alerts our publication covered throughout the month, giving readers a...
09/01/2026
FDA Approval
FDA Approval
08/07/2026
Anthony Calabro, MA
The FDA approved an mRNA-based influenza vaccine mFLUSIVA for adults aged 50 years and older, with accelerated approval applying to adults aged 65 years and older.
08/07/2026
Respiratory Diseases Roundup
Respiratory Diseases Roundup
08/04/2026
Ashton L. Stahl
New influenza and RSV research offers clinically relevant insights into vaccine performance and outbreak prevention. This roundup examines an investigational mRNA flu vaccine, rapid oseltamivir use in...
08/04/2026